Facebook
Twitter
Telegram
Report an ErrorArcturus Therapeutics Holdings Financial Ratios 2011-2024 | ARCT
Annual Financial Ratios Arcturus Therapeutics Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-32.6 | 102.9 | -3.4 | -20.4 | -4.8 | -2.3 | -2.3 | -1.2 | -5.7 | -2.6 | -21.1 | -13.1 | - |
P/S |
5.8 | 4.7 | 55.6 | 154.2 | 6.0 | 3.2 | 1.9 | - | - | - | - | - | - |
EPS |
-1.1 | 0.3 | -7.7 | -3.5 | -2.1 | -2.2 | - | - | - | - | - | - | - |
EV (Enterprise Value) |
827 M | 750 M | 482 M | 1.09 B | 110 M | 44.2 M | 17.7 M | 33 M | 113 M | 86.7 M | 224 M | 21.4 M | 219 K |
EBITDA per Share |
-2.83 | 0.52 | -7.66 | -3.48 | -2.06 | -2.11 | -3.27 | -6.38 | -6.36 | -16.9 | -7.06 | -0.939 | - |
EV/EBITDA |
-2.4 | -14.5 | -2.8 | -1.1 | 0.0 | -1.0 | -4.8 | -2.5 | -19.5 | -14.2 | - | ||
PEG |
0.29 | 11.53 | -0.16 | 0.11 | -10.38 | -0.06 | -0.05 | -1.05 | -0.09 | 0.02 | 0.03 | -0.21 | - |
P/B |
3.5 | 3.6 | 3.0 | 3.7 | 4.8 | 3.7 | 0.7 | 0.6 | 1.6 | 4.2 | 4.6 | -36.5 | - |
P/CF |
-53.5 | 30.1 | -5.1 | -33.0 | -17.2 | -2.3 | -34.7 | -1.5 | -6.0 | -3.0 | -30.1 | -13.0 | - |
ROE % |
-10.67 | 3.46 | -89.25 | -18.19 | -100.77 | -159.69 | -32.26 | -52.09 | -28.05 | -164.64 | -21.66 | 278.48 | - |
ROA % |
-6.92 | 2.08 | -51.85 | -15.14 | -31.64 | -49.29 | -20.96 | -47.71 | -27.13 | -147.12 | -20.96 | -785.57 | - |
ROCE % |
-28.08 | 4.50 | -88.89 | -16.75 | -41.95 | -68.98 | -25.60 | -53.29 | -28.41 | -165.86 | -21.13 | 264.73 | - |
Current Ratio |
2.8 | 2.5 | 2.4 | 9.4 | 3.5 | 3.3 | 4.6 | 11.8 | 22.3 | 9.3 | 30.7 | 0.2 | - |
DSO |
38.1 | 5.4 | 81.1 | 81.3 | 38.3 | 103.8 | 13.5 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
38.1 | 5.4 | 81.1 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
38.1 | 5.4 | 81.1 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Arcturus Therapeutics Holdings
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.61 | -1.98 | 1.91 | - | -1.33 | -0.82 | -1.94 | -1.47 | -2.05 | -2.07 | -2.15 | -1.25 | -0.92 | -0.55 | -0.67 | -0.76 | -0.56 | -0.07 | -0.68 | - | -0.42 | -0.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-697 | -2.06 K | 577 | - | -1.38 K | -821 | -1.9 K | -1.43 | -2.03 | -2.03 | -2.19 | -1.25 | -0.9 | -0.52 | -0.64 | -0.75 | -0.56 | -0.04 | -0.63 | - | -0.41 | -0.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-33.01 | -51.43 | -45.64 | -64.54 | -81.48 | -78.14 | -83.37 | -71.65 | -62.55 | -46.98 | -31.71 | -18.19 | -52.96 | -76.48 | -76.55 | -100.77 | -89.34 | -91.70 | -161.98 | -104.11 | -104.11 | -72.94 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-16.98 | -25.44 | -19.64 | -33.37 | -43.21 | -43.65 | -49.41 | -46.15 | -42.84 | -34.80 | -24.79 | -15.14 | -21.99 | -26.63 | -25.31 | -31.64 | -27.89 | -28.46 | -50.14 | -32.13 | -32.13 | -22.51 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-47.10 | -65.47 | -58.99 | -65.48 | -81.97 | -77.47 | -82.11 | -71.20 | -62.54 | -47.05 | -32.00 | -18.04 | -52.14 | -76.39 | -76.07 | -98.92 | -88.91 | -91.31 | -162.93 | -105.76 | -105.76 | -73.83 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
2.6 | 3.0 | 3.3 | 2.5 | 2.0 | 2.0 | 2.2 | 2.4 | 2.5 | 3.1 | 3.7 | 6.0 | 6.0 | 6.0 | 6.0 | 1.5 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
41.5 | 413.3 | 54.1 | - | 14.6 | 10.0 | 61.4 | 42.4 | 78.2 | 95.1 | 88.6 | 86.6 | 83.1 | 83.5 | 74.2 | 67.0 | 59.9 | 19.6 | 69.8 | - | 119.5 | 85.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
41.5 | 413.3 | 54.1 | - | 14.6 | 10.0 | 61.4 | 42.4 | 78.2 | 95.1 | 88.6 | 86.6 | 83.1 | 83.5 | 74.2 | 67.0 | 59.9 | 19.6 | 69.8 | - | 119.5 | 85.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
41.5 | 413.3 | 54.1 | - | 14.6 | 10.0 | 61.4 | 42.4 | 78.2 | 95.1 | 88.6 | 86.6 | 83.1 | 83.5 | 74.2 | 67.0 | 59.9 | 19.6 | 69.8 | - | 119.5 | 85.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency